Point72 »

Xylem shares owned by Point72

Quarter-by-quarter ownership of Xylem (XYL) shares owned by Point72 from 13F filings

Historical chart of Point72 investment in Xylem

Tip: Access up to 7 years of quarterly data

All positions including Xylem held by Point72 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xylem by Point72

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.9M 22k 135.63
2024-03-31 $109k 842 129.25

More positions owned by Point72

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Apple (AAPL)
Pfizer (PFE)
Adobe Systems Incorporated Call Option (ADBE)
Amgen Call Option (AMGN)
salesforce Call Option (CRM)
Bristol Myers Squibb (BMY)
Amazon (AMZN)
Raytheon Technologies Corp (RTX)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
Visa Com Cl A (V)
Spotify Technology S A SHS (SPOT)
Eli Lilly & Co. Call Option (LLY)

View all positions for Point72

Top funds holding Xylem

Vanguard Group
BlackRock
State Street Corporation
Reed Conner & Birdwell
Geode Capital Management
Morgan Stanley
Artisan Partners Limited Partnership
Royal Bank of Canada
Invesco
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Swedbank AB
American Century Companies
Bank of America Corporation
Goldman Sachs Group
Baillie Gifford & Co

View all funds holding Xylem